Biomedical Engineering Reference
In-Depth Information
Once each pursued as separate methods, innovation and collaboration between
disparate disciplines has led to combinatorial approaches and improved success.
References
1. Andersson G (2008) American academy of orthopaedic surgeons: the burden of
musculoskeletal diseases in the United States: prevalence societal and economic cost.
American Academy of Orthopaedic Surgeons, Rosemont
2. Brooks SV (2003) Current topics for teaching skeletal muscle physiology. Adv Physiol Educ
27(1-4):171-182
3. Tedesco FS, Dellavalle A, Diaz-Manera J, Messina G, Cossu G (2010) Repairing skeletal
muscle: regenerative potential of skeletal muscle stem cells. J Clin Invest 120(1):11-19
4. Andia I, Sanchez M, Maffulli N (2011) Platelet rich plasma therapies for sports muscle
injuries: any evidence behind clinical practice? Expert Opin Biol Ther 11(4):509-518
5. Stauber WT, Knack KK, Miller GR, Grimmett JG (1996) Fibrosis and intercellular collagen
connections from four weeks of muscle strains. Muscle Nerve 19(4):423-430
6. Hagg GM (2000) Human muscle fibre abnormalities related to occupational load. Eur J Appl
Physiol 83(2-3):159-165
7. Tiidus PM (2008) Skeletal muscle damage and repair. Human Kinetics, Champaign
8. Conboy IM, Conboy MJ, Wagers AJ, Girma ER, Weissman IL, Rando TA (2005)
Rejuvenation of aged progenitor cells by exposure to a young systemic environment. Nature
433(7027):760-764
9. McNeil DE, Davis C, Jillapalli D, Targum S, Durmowicz A, Cote TR (2010) Duchenne
muscular
dystrophy:
drug
development
and
regulatory
considerations.
Muscle
Nerve
41(6):740-745
10. Rocha CT, Hoffman EP (2010) Limb-girdle and congenital muscular dystrophies: current
diagnostics, management, and emerging technologies. Curr Neurol Neurosci Rep 10(4):
267-276
11. Mishra DK, Friden J, Schmitz MC, Lieber RL (1995) Anti-inflammatory medication after
muscle injury. A treatment resulting in short-term improvement but subsequent loss of
muscle function. J Bone Joint Surg Am 77(10):1510-1519
12. Shen W, Li Y, Tang Y, Cummins J, Huard J (2005) NS-398, a cyclooxygenase-2-specific
inhibitor, delays skeletal muscle healing by decreasing regeneration and promoting fibrosis.
Am J Pathol 167(4):1105-1117
13. Mackey AL, Kjaer M, Dandanell S, Mikkelsen KH, Holm L, Dossing S, Kadi F, Koskinen
SO, Jensen CH, Schroder HD, Langberg H (2007) The influence of anti-inflammatory
medication on exercise-induced myogenic precursor cell responses in humans. J Appl Physiol
103(2):425-431
14. Biggar WD, Harris VA, Eliasoph L, Alman B (2006) Long-term benefits of deflazacort
treatment for boys with duchenne muscular dystrophy in their second decade. Neuromuscul
Disord 16(4):249-255
15. Nagaraju K (2001) Immunological capabilities of skeletal muscle cells. Acta Physiol Scand
171(3):215-223
16. Chazaud B, Sonnet C, Lafuste P, Bassez G, Rimaniol AC, Poron F, Authier FJ, Dreyfus PA,
Gherardi RK (2003) Satellite cells attract monocytes and use macrophages as a support to
escape apoptosis and enhance muscle growth. J Cell Biol 163(5):1133-1143
17. Conboy IM, Rando TA (2002) The regulation of notch signaling controls satellite cell
activation and cell fate determination in postnatal myogenesis. Dev Cell 3(3):397-409
18. Sacco A, Doyonnas R, Kraft P, Vitorovic S, Blau HM (2008) Self-renewal and expansion of
single transplanted muscle stem cells. Nature 456(7221):502-506
